+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Europe Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type; Drug Type; Treatment Center; Distribution Channel and Country

  • ID: 5236415
  • Report
  • December 2020
  • Region: Europe
  • 101 pages
  • The Insight Partners
UP TO OFF
until Jun 30th 2021
1 of 3

FEATURED COMPANIES

  • Alvogen
  • Camurus AB
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Indivior PLC
  • MORE
Nicotine addiction treatment segment by type is estimated to lead the market growth during the forecast period

According to a new market research study of “Europe Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type, Drug Type, Treatment Centre, and Distribution Channel,” The Europe Addictions Therapeutics market is expected to reach US$ 2,147.19 million in 2027 from US$ 1,410.85 million in 2019. The market is estimated to grow with a CAGR of 5.5% from 2020 to 2027. The report highlights trends prevailing in the Europe Addictions Therapeutics market and the factors driving market along with those that act as hindrances.

Based on treatment type, the Europe addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. Drug addiction, also referred to as substance disorder, is a type of disease that hampers an individual’s brain, behavior, and metabolic processes leading to an inability to control. Nonmedical use and abuse of prescription drugs are becoming severe issues worldwide. Addiction to abusive substances is responsible for the death of millions of people across the world. The Addiction Centre report estimated that over 11% of France's population consumed cannabis at some point, and 41,000 people died due to alcohol-related causes between 2015 and 2017. The reports also stated that the number of people undertaking treatments for these addictions has increased in the recent years. Thus, the rising awareness among people about drug addiction treatment is likely to support the growth of the Europe addiction therapeutics market in the coming years. Similarly, awareness campaigns and government efforts to counteract drug abuse and promote medication for all sorts of addiction treatments would fuel the market growth during the forecast period.

The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high costs associated with drug development is hindering the growth of the addiction therapeutics market.

Indivior PLC, Pfizer Inc.and GlaxoSmithKline plc are among the leading companies operating in the Europe addictions therapeutics market.

The report segments in Europe Addictions Therapeutics market as follows:

By Treatment Type
  • Opioid Addiction Treatment
  • Alcohol Addiction Treatment
  • Nicotine Addiction Treatment
  • Other Substance Addiction Treatment
By Drug Type
  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine Replacement Products
  • Varenicline
  • Others
By Treatment Center
  • Inpatient Treatment Center
  • Residential Treatment Center
  • Outpatient Treatment Center
By Distribution Channel
  • Hospital Pharmacies
  • Medical stores
  • Others
By Country
  • China
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
Reasons to Buy
  • Determine prospective investment areas based on a detailed trend analysis of the Europe addictions therapeutics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the Europe addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe addictions therapeutics market.
Note: Product cover images may vary from those shown
2 of 3

FEATURED COMPANIES

  • Alvogen
  • Camurus AB
  • Cipla Inc.
  • GlaxoSmithKline plc
  • Hikma Pharmaceuticals PLC
  • Indivior PLC
  • MORE
1. Introduction
1.1 Scope of the Study
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 Europe Addictions Therapeutics Market - By Treatment Type
1.3.2 Europe Addictions Therapeutics Market - By Drug Type
1.3.3 Europe Addictions Therapeutics Market - By Treatment Center
1.3.4 Europe Addictions Therapeutics Market - By Distribution Channel
1.3.5 Europe Addictions Therapeutics Market - By Country

2. Addictions Therapeutics Market - Key Takeaways

3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research

4. Addiction Therapeutics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Europe - PEST Analysis

5. Addiction Therapeutics Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Rising Addiction Among General Populace
5.1.2 Conduction of Awareness Campaigns
5.2 Market Restraint
5.2.1 Steeping Costs of Drug Development
5.3 Market Opportunity
5.3.1 Rising Demand for R&D from Contract Organizations
5.4 Future Trend
5.4.1 Consistent Launch of Therapeutics
5.5 Impact Analysis

6. Addiction Therapeutics Market - Europe Analysis
6.1 Europe Addictions Therapeutics Marker Revenue Forecast and Analysis

7. Addictions Therapeutics Market- Treatment Type
7.1 Overview
7.2 Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
7.3 Nicotine Addiction Treatment
7.3.1 Overview
7.3.1.1 Nicotine Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
7.4 Alcohol Addiction Treatment
7.4.1 Overview
7.4.1.1 Alcohol Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
7.5 Opioid Addiction Treatment
7.5.1 Overview
7.5.1.1 Opioid Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
7.6 Other Substance Addiction Treatment
7.6.1 Overview
7.6.2 Other Substance Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)

8. Addictions Therapeutics Market- Drug Type
8.1 Overview
8.2 Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
8.3 Varenicline
8.3.1 Overview
8.3.1.1 Varenicline: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.4 Bupropion
8.4.1 Overview
8.4.1.1 Bupropion: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.5 Nicotine Replacement Products
8.5.1 Overview
8.5.1.1 Nicotine Replacement Products: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.6 Buprenorphine
8.6.1 Overview
8.6.1.1 Buprenorphine: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.7 Naltrexone
8.7.1 Overview
8.7.1.1 Naltrexone: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.8 Disulfiram
8.8.1 Overview
8.8.1.1 Disulfiram: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
8.9 Others
8.9.1 Overview
8.9.1.1 Others: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)

9. Addictions Therapeutics Market- Treatment Centre
9.1 Overview
9.2 Addictions Therapeutics Market Share, Treatment Centre, 2019 and 2027 (%)
9.3 Outpatient Treatment Centre
9.3.1 Overview
9.3.1.1 Outpatient Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
9.4 Residential Treatment Center
9.4.1 Overview
9.4.1.1 Residential Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
9.5 Inpatient Treatment Center
9.5.1 Overview
9.5.1.1 Inpatient Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)

10. Addictions Therapeutics Market- Distribution Channel
10.1 Overview
10.2 Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
10.3 Hospital Pharmacies
10.3.1 Overview
10.3.1.1 Hospital Pharmacies: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
10.4 Medical Stores
10.4.1 Overview
10.4.1.1 Medical Stores: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
10.5 Others
10.5.1 Overview
10.5.1.1 Others: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)

11. Addiction Therapeutics Market Analysis and Forecasts To 2027 - Europe Analysis
11.1 Europe: Addiction Therapeutics Market
11.1.1 Overview
11.1.2 Europe: Addiction Therapeutics Market, - Revenue and Forecast to 2027 (USD Million)
11.1.3 Europe: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.4 Europe: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.4.1 Europe: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.5 Europe: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.6 Europe: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
11.1.7 Germany: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.7.1 Germany: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.7.2 Germany: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.7.3 Germany: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.7.4 Germany: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.7.5 Germany: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.8 UK: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.1 UK: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.8.2 UK: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.3 UK: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.8.4 UK: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.8.5 UK: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.9 France: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.1 France: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.9.2 France: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.3 France: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.9.4 France: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.9.5 France: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.10 Italy: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.1 Italy: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.10.2 Italy: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.3 Italy: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.10.4 Italy: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.10.5 Italy: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.11 Spain: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.1 Spain: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.11.2 Spain: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.11.3 Spain: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.11.4 Spain: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.11.5 Spain: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
11.1.12 Rest of Europe: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.1 Rest of Europe: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
11.1.12.2 Rest of Europe: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
11.1.12.3 Rest of Europe: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
11.1.12.4 Rest of Europe: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
11.1.12.5 Rest of Europe: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)

12. Impact of COVID-19 Pandemic on Europe Addiction Therapeutics Market
12.1 Europe: Impact Assessment Of COVID-19 Pandemic

13. Company Profiles
13.1 Indivior PLC
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 Pfizer Inc.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 GlaxoSmithKline plc.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 Bausch Health Companies Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 Cipla Inc.
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Orexo AB
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 Purdue Pharma L.P.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 Alvogen
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 Hikma Pharmaceuticals PLC
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments

14. Appendix
14.1 About the Publisher
14.2 Glossary of Terms

List of Tables
Table 1. Europe: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 2. Europe: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 3. Europe: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 4. Europe: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 5. Germany: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 6. Germany: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 7. Germany: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 8. Germany: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 9. UK: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 10. UK: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 11. UK: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 12. UK: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 13. France: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 14. France: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 15. France: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 16. France: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 17. Italy: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 18. Italy: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 19. Italy: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 20. Italy: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 21. Spain: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 22. Spain: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 23. Spain: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 24. Spain: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 25. Rest of Europe: Addiction Therapeutics Market, by Treatment Type - Revenue and Forecast to 2027 (USD Million)
Table 26. Rest of Europe: Addiction Therapeutics Market, by Drug Type - Revenue and Forecast to 2027 (USD Million)
Table 27. Rest of Europe: Addiction Therapeutics Market, by Treatment Center - Revenue and Forecast to 2027 (USD Million)
Table 28. Rest of Europe: Addiction Therapeutics Market, by Distribution Channel - Revenue and Forecast to 2027 (USD Million)
Table 29. Glossary of Terms, Medical Adhesive and Sealants Market

List of Figures
Figure 1. Addictions Therapeutics Market Segmentation
Figure 2. Addictions Therapeutics Market - By Country
Figure 3. Addictions Therapeutics Market Overview
Figure 4. Nicotine Addiction Treatment Segment Held Largest Share of Addictions Therapeutics Market
Figure 5. Europe Addictions Therapeutics Market - Leading Country Markets (US$ Million)
Figure 6. Europe PEST Analysis
Figure 7. Addiction Therapeutics Market Impact Analysis of Drivers and Restraint
Figure 8. Europe Addictions Therapeutics Market - Revenue Forecast and Analysis - 2019- 2027
Figure 9. Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)
Figure 10. Nicotine Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 11. Alcohol Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 12. Opioid Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 13. Other Substance Addiction Treatment: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 14. Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)
Figure 15. Varenicline: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 16. Bupropion: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 17. Nicotine Replacement Products: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 18. Buprenorphine: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 19. Naltrexone: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 20. Disulfiram: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 21. Others: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 22. Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)
Figure 23. Outpatient Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 24. Residential Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 25. Inpatient Treatment Center: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 26. Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)
Figure 27. Hospital Pharmacies: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 28. Medical Stores: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 29. Others: Addictions Therapeutics Market- Revenue and Forecast to 2027 (US$ million)
Figure 30. Europe: Addiction Therapeutics Market, by Key Country - Revenue (2019) (USD Million)
Figure 31. Europe: Addiction Therapeutics Market, Revenue and Forecast to 2027 (USD Million)
Figure 32. Europe: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)
Figure 33. Germany: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 34. UK: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 35. France: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 36. Italy: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 37. Spain: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 38. Rest of Europe: Addiction Therapeutics Market - Revenue and Forecast to 2027 (USD Million)
Figure 39. Impact of COVID-19 Pandemic in European Country Markets
Note: Product cover images may vary from those shown
3 of 3
  • Indivior PLC
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC
Note: Product cover images may vary from those shown
Adroll
adroll